title: ASCP policy statement use of antipsychotic medications in nursing facility residents.
abstract: In May 2011, the Office of Inspector General (OIG) of the Department of Health and Human Services issued a report on the use of atypical antipsychotic medications in elderly nursing facility residents. The report found that 95% of the use of these medications was either for off-label use or in patients for whom a "black box" warning was applicable. The report described the use of these medications as "unnecessary" and "inappropriate." The Board of Directors of the American Society of Consultant Pharmacists has approved this position statement as part of an effort to provide context and clinical background that was missing from the OIG report.
mesh_terms: D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000009:adverse effects*; D006801:Humans; D009735:Nursing Homes / Q000592:standards*; D056687:Off-Label Use / Q000592:standards*; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D014150:Antipsychotic Agents